Federal Register / Vol. 65, No. 194 / Thursday, October 5, 2000 / Notices 59453

National Cancer Institute, 6116 Executive

Boulevard, Suite 300 C, Bethesda, MD 20892,

301/594–3194.

This notice is being published less than 15

days prior to the meeting due to scheduling

conflicts.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: September 26, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–25539 Filed 10–4–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Meeting

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

President’s Cancer Panel.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: President’s Cancer

Panel.

Date: November 16–17, 2000.

Time: 9:00 AM to 4:00 PM.

Agenda: Town Hall Meeting to review

Improving Cancer Care for All: Real People—

Real Problems.

Place: Vanderbilt University, Vanderbilt

Cancer Center, Medical Research Building II,

Nashville, TN 37322–6838.

Contact Person: Maureen O. Wilson,

Executive Secretary, National Cancer

Institute, National Institutes of Health, 31

Center Drive, Building 31, room 4A48,

Bethesda, MD 20892, 301/496–1148.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: September 26, 2000.

Laverne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–25540 Filed 10–4–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel,

Institutional Clinical Oncology Research

Career Development Program PAR–00–63.

Date: October 11, 2000.

Time: 5 PM to 6 PM.

Agenda: To review and evaluate grant

applications.

Place: Holiday Inn—Georgetown, 2101

Wisconsin Avenue, N.W., Washington, DC

20007.

Contact Person: David E. Maslow,

Scientific Review Administrator, Grants

Review Branch, Division of Extramural

Activities, National Cancer Institute, National

Institutes of Health, 6116 Executive

Boulevard—Room 8054, Bethesda, MD

20892–7405, 301/496–2330.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Assistance Program

Nos. 93.392, Cancer Construction, 93.393,

Cancer Cause and Prevention Research;

93.394, Cancer Detection and Diagnosis

Research; 93.395, Cancer Treatment

Research; 93.396, Cancer Biology Research;

93.397, Cancer Centers Support; 93.398,

Cancer Research Manpower; 93.399, Cancer

Control, National Institutes of Health, HHS)

Dated: September 27, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–25542 Filed 10–4–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health, National

Cancer Institute; Notice of Meeting

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Advisory Committee to the Director,

National Cancer Institute.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: Advisory Committee

to the Director, National Cancer Institute.

Date: November 6, 2000.

Time: 9:30 AM to 11:00 PM.

Agenda: The purpose of this meeting will

be to discuss the Brain Tumor Progress

Review Group Report.

Place: National Institutes of Health, 9000

Rockville Pike, Building 31, Room 11A10,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Susan J. Waldrop,

Executive Secretary, National Institutes of

Health, National Cancer Institute, Office of

Science Policy, Bethesda, MD 20892, 301/

496–1458.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: September 27, 2000.

LaVerne Y. Stringfield

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–25543 Filed 10–4–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Meeting;

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

Sickle Cell Disease Advisory

Committee.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such